Silo Pharma, Inc. (NASDAQ:SILO) Short Interest Update

Silo Pharma, Inc. (NASDAQ:SILO) was the recipient of a significant decrease in short interest during the month of December. As of December 31st, there was short interest totalling 212,900 shares, a decrease of 21.8% from the December 15th total of 272,100 shares. Currently, 5.0% of the shares of the stock are short sold. Based on an average daily volume of 2,920,000 shares, the short-interest ratio is currently 0.1 days.

Silo Pharma Price Performance

Shares of Silo Pharma stock traded up $0.23 during trading on Thursday, reaching $1.98. 575,845 shares of the company’s stock were exchanged, compared to its average volume of 17,854,480. Silo Pharma has a 1-year low of $0.77 and a 1-year high of $4.50. The firm’s 50-day moving average price is $1.08 and its 200 day moving average price is $1.24.

About Silo Pharma

Silo Pharma Inc operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations and drug delivery systems.